-
USAID recognizes World TB day and the global shared effort to End TB.
-
On October 30, 2017 the WHO released the 2017 Global TB Report. The report is a comprehensive assessment of the TB epidemic and includes progress in prevention, diagnosis and treatment of the disease at global, regional and country levels.
-
Administrator Green spoke about ending the tuberculosis epidemic in India during his November 2017 trip.
-
Through technical assistance led by the U.S. Agency for International Development (USAID) and our innovative partnership with Johnson & Johnson, we are scaling up multidrug-resistant TB treatment programs in over 25 countries.
-
As the lead U.S. Government agency for global TB care, USAID works with partners to reach every person with TB, cure those in need of treatment and prevent new TB infections.
At USAID, we focus our investments on strengthening national TB strategies and programs through bilateral programs in priority countries with high rates of TB, drug-resistant TB and HIV-associated TB.




The U.S. Agency for International Development (USAID) supports high-quality screening, diagnosis and treatment services for millions of people affected by TB and multidrug-resistant tuberculosis (MDR-TB). In Fiscal Year 2016, with investments of $242 million focused primarily in 23 countries with bilateral TB funds, the U.S. Government achieved the following results in collaboration with each country's National TB Program:
23 |
Countries with bilateral programs |
54 |
Countries received technical assistance |
3,900,000 |
TB cases detected |
5 |
Percent increase in case notifications |
77,000 |
Individuals with DR-TB started on appropriate treatment |
23,000,000 |
Xpert cartridges procured under concessional pricing (cumulative) |
56 |
Countries utilized the Bedaquiline Donation Program (cumulative) |
46,000 |
Health workers trained |
18 |
Countries completed drug-resistance surveys (cumulative) |
14 |
Countries completed/completing TB prevalence surveys (cumulative) |
5 |
Research studies focused on new treatment regimens supported |
USAID's investments contributed to an estimated 53 million lives saved from 2000-2016, including people co-infected with HIV/AIDS.
What We Do
USAID works with partner governments to:
- Prevent TB transmission and renew efforts to find the missing TB cases
- Strengthen the capacity of national TB programs
- Build country capacity to use existing resources and to turn evidence into policy
- Expand the development of new TB diagnostics, drugs and vaccines
Last updated: March 23, 2018
Comment
Make a general inquiry or suggest an improvement.